NK cells in central nervous system disorders

Journal of Immunology

Volumn 190, Issue 11, 2013, Pages 5355-5362

  Poli, Aurélie ^a,b   Kmiecik, Justyna ^b   Domingues, Olivia ^a   Hentges, François ^a   Bléry, Mathieu ^c   Chekenya, Martha ^b   Boucraut, José ^d,e   Zimmer, Jacques ^a  

^a Public Research Center for Health   (Luxembourg)

^b UNIVERSITY OF BERGEN   (Norway)

^c INNATE PHARMA   (France)

^d University of Mediterranée   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; DACLIZUMAB; GAMMA INTERFERON; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; BACTERIAL MENINGITIS; BRAIN MALARIA; BRAIN TUMOR; CAUSAL ATTRIBUTION; CD4+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL INFILTRATION; CELL MATURATION; CELL THERAPY; CENTRAL NERVOUS SYSTEM DISEASE; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROVASCULAR ACCIDENT; CYTOKINE RELEASE; DEPRESSION; GLIOBLASTOMA; HERPES SIMPLEX ENCEPHALITIS; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHORT SURVEY; TRAUMATIC BRAIN INJURY; VIRUS IMMUNITY;

ANIMALS; BRAIN; CENTRAL NERVOUS SYSTEM DISEASES; HUMANS; KILLER CELLS, NATURAL; PHENOTYPE;

EID: 84878074164     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203401     Document Type: Short Survey

References (96)

1. Ransohoff, R. M., and B. Engelhardt. 2012. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12: 623-635.
2. Domingues, P. H., C. Teodósio, J. Ortiz, P. Sousa, A. Otero, A. Maillo, P. Bárcena, M. C. García-Macias, M. C. Lopes, C. de Oliveira, et al. 2012. Immunophenotypic identification and characterization of tumor cells and infiltrating cell populations in meningiomas. Am. J. Pathol. 181: 1749-1761.
3. Trifilo, M. J., C. Montalto-Morrison, L. N. Stiles, K. R. Hurst, J. L. Hardison, J. E. Manning, P. S. Masters, and T. E. Lane. 2004. CXC chemokine ligand 10 controls viral infection in the central nervous system: evidence for a role in innate immune response through recruitment and activation of natural killer cells. J. Virol. 78: 585-594. (Pubitemid 38067580)
4. Alsharifi, M., M. Lobigs, M. M. Simon, A. Kersten, K. Müller, A. Koskinen, E. Lee, and A. Müllbacher. 2006. NK cell-mediated immunopathology during an acute viral infection of the CNS. Eur. J. Immunol. 36: 887-896.
5. Hao, J., D. Campagnolo, R. Liu, W. Piao, S. Shi, B. Hu, R. Xiang, Q. Zhou, T. Vollmer, L. Van Kaer, et al. 2011. Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation. Ann. Neurol. 69: 721-734.
6. Cédile, O., N. Popa, F. Pollet-Villard, N. Garmy, E. C. Ibrahim, and J. Boucraut. 2010. The NKG2D ligands RAE-1δ and RAE-1ε differ with respect to their receptor affinity, expression profiles and transcriptional regulation. PLoS ONE 5: e13466.
7. Lünemann, A., J. D. Lünemann, and C. Münz. 2009. Regulatory NK-cell functions in inflammation and autoimmunity. Mol. Med. 15: 352-358.
8. Hayakawa, Y., and M. J. Smyth. 2006. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J. Immunol. 176: 1517-1524. (Pubitemid 43134295)
9. Caligiuri, M. A. 2008. Human natural killer cells. Blood 112: 461-469.
10. bright natural killer (NK) cells: an important NK cell subset. Immunology 126: 458-465.
11. Logan, R. W., A. Arjona, and D. K. Sarkar. 2011. Role of sympathetic nervous system in the entrainment of circadian natural-killer cell function. Brain Behav. Immun. 25: 101-109.
12. Lünemann, A., J. D. Lünemann, S. Roberts, B. Messmer, R. Barreira da Silva, C. S. Raine, and C. Münz. 2008. Human NK cells kill resting but not activated microglia via NKG2D- and NKp46-mediated recognition. J. Immunol. 181: 6170-6177.
13. Walter, J., S. D. Honsek, S. Illes, J. M. Wellen, H. P. Hartung, C. R. Rose, and M. Dihné. 2011. A new role for interferon gamma in neural stem/precursor cell dysregulation. Mol. Neurodegener. 6: 18.
14. Hao, J., R. Liu, W. Piao, Q. Zhou, T. L. Vollmer, D. I. Campagnolo, R. Xiang, A. La Cava, L. Van Kaer, and F. D. Shi. 2010. Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J. Exp. Med. 207: 1907-1921.
15. Winkler-Pickett, R., H. A. Young, J. M. Cherry, J. Diehl, J. Wine, T. Back, W. E. Bere, A. T. Mason, and J. R. Ortaldo. 2008. In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses. J. Immunol. 180: 4495-4506.
16. Flodström-Tullberg, M., Y. T. Bryceson, F. D. Shi, P. Höglund, and H. G. Ljunggren. 2009. Natural killer cells in human autoimmunity. Curr. Opin. Immunol. 21: 634-640.
17. Hiby, S. E., J. J. Walker, K. M. O'shaughnessy, C. W. Redman, M. Carrington, J. Trowsdale, and A. Moffett. 2004. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200: 957-965. (Pubitemid 39431121)
18. Shi, F. D., H. G. Ljunggren, A. La Cava, and L. Van Kaer. 2011. Organ-specific features of natural killer cells. Nat. Rev. Immunol. 11: 658-671.
19. Wrona, D. 2006. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune systems. J. Neuroimmunol. 172: 38-58. (Pubitemid 43277489)
20. Parney, I. F. 2012. Basic concepts in glioma immunology. Adv. Exp. Med. Biol. 746: 42-52.
21. Fadul, C. E., J. L. Fisher, J. Gui, T. H. Hampton, A. L. Côté, and M. S. Ernstoff. 2011. Immune modulation effects of concomitant temozolomide and radiation therapy on peripheral blood mononuclear cells in patients with glioblastoma multiforme. Neuro-oncol. 13: 393-400.
22. Servade, F., R. Parente, M. Bucci, E. Beltrandi, F. Tognetti, and G. Gaist. 1983. Particular features of cell-mediated immunity in patients with anaplastic gliomas: a comparison with kidney and bladder cancer patients. J. Neurooncol. 1: 327-332. (Pubitemid 14163773)
23. Alizadeh, D., L. Zhang, C. E. Brown, O. Farrukh, M. C. Jensen, and B. Badie. 2010. Induction of anti-glioma natural killer cell response following multiple low-dose intracerebral CpG therapy. Clin. Cancer Res. 16: 3399-3408.
24. + T cells in glioma patients. Neuro-oncol. 12: 7-13.
25. Groth, A., S. Klöss, E. P. von Strandmann, U. Koehl, and J. Koch. 2011. Mechanisms of tumor and viral immune escape from natural killer cell-mediated surveillance. J. Innate Immun. 3: 344-354.
26. Biron, C. A., K. S. Byron, and J. L. Sullivan. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320: 1731-1735. (Pubitemid 19163129)
27. Almerigogna, F., F. Fassio, M. G. Giudizi, R. Biagiotti, C. Manuelli, E. Chiappini, L. Galli, S. Romagnani, and M. De Martino. 2011. Natural killer cell deficiencies in a consecutive series of children with herpetic encephalitis. Int. J. Immunopathol. Pharmacol. 24: 231-238.
28. Adler, H., J. L. Beland, N. C. Del-Pan, L. Kobzik, R. A. Sobel, and I. J. Rimm. 1999. In the absence of T cells, natural killer cells protect from mortality due to HSV-1 encephalitis. J. Neuroimmunol. 93: 208-213. (Pubitemid 29051567)
29. Zimmer, J., E. Andrès, L. Donato, D. Hanau, F. Hentges, and H. de la Salle. 2005. Clinical and immunological aspects of HLA class I deficiency. QJM 98: 719-727. (Pubitemid 41548549)
30. Zhang, S. Y., E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D. Segal, V. Sancho-Shimizu, L. Lorenzo, A. Puel, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317: 1522-1527. (Pubitemid 47417427)
31. Paya, C. V., A. K. Patick, P. J. Leibson, and M. Rodriguez. 1989. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 143: 95-102. (Pubitemid 19174205)
32. Walsh, K. B., R. A. Edwards, K. M. Romero, M. V. Kotlajich, S. A. Stohlman, and T. E. Lane. 2007. Expression of CXC chemokine ligand 10 from the mouse hepatitis virus genome results in protection from viral-induced neurological and liver disease. J. Immunol. 179: 1155-1165.
33. Shieh, T. M., D. L. Carter, R. L. Blosser, J. L. Mankowski, M. C. Zink, and J. E. Clements. 2001. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus. J. Neurovirol. 7: 11-24. (Pubitemid 32904354)
34. + T cells in central nervous system listeriosis. J. Immunol. 182: 6360-6368.
35. Jin, Y., L. Dons, K. Kristensson, and M. E. Rottenberg. 2001. Neural route of cerebral Listeria monocytogenes murine infection: role of immune response mechanisms in controlling bacterial neuroinvasion. Infect. Immun. 69: 1093-1100. (Pubitemid 32109577)
36. Mitchell, A. J., B. Yau, J. A. McQuillan, H. J. Ball, L. K. Too, A. Abtin, P. Hertzog, S. L. Leib, C. A. Jones, S. K. Gerega, et al. 2012. Inflammasome-dependent IFN-γ drives pathogenesis in Streptococcus pneumoniae meningitis. J. Immunol. 189: 4970-4980.
37. Stach, J. L., E. Dufrenoy, J. Roffi, and M. A. Bach. 1986. T-cell subsets and natural killer activity in Plasmodium falciparum-infected children. Clin. Immunol. Immunopathol. 38: 129-134. (Pubitemid 16232247)
38. + T cells to the brain during Plasmodium berghei-mediated cerebral malaria. J. Immunol. 178: 5779-5788.
39. Ryg-Cornejo, V., C. Q. Nie, N. J. Bernard, R. J. Lundie, K. J. Evans, B. S. Crabb, L. Schofield, and D. S. Hansen. 2013. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection. Immunobiology 218: 263-271.
40. + T cell accumulation within the brain. J. Immunol. 189: 968-979.
41. De Chiara, G., M. E. Marcocci, R. Sgarbanti, L. Civitelli, C. Ripoli, R. Piacentini, E. Garaci, C. Grassi, and A. T. Palamara. 2012. Infectious agents and neurodegeneration. Mol. Neurobiol. 46: 614-638.
42. Pellicanò, M., A. Larbi, D. Goldeck, G. Colonna-Romano, S. Buffa, M. Bulati, G. Rubino, F. Iemolo, G. Candore, C. Caruso, et al. 2012. Immune profiling of Alzheimer patients. J. Neuroimmunol. 242: 52-59.
43. Speciale, L., E. Calabrese, M. Saresella, C. Tinelli, C. Mariani, L. Sanvito, R. Longhi, and P. Ferrante. 2007. Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients. Neurobiol. Aging 28: 1163-1169. (Pubitemid 46810052)
44. Richartz-Salzburger, E., A. Batra, E. Stransky, C. Laske, N. Köhler, M. Bartels, G. Buchkremer, and K. Schott. 2007. Altered lymphocyte distribution in Alzheimer's disease. J. Psychiatr. Res. 41: 174-178. (Pubitemid 44708214)
45. 2C in natural killer cells in Alzheimer's dementia. J. Neuroimmunol. 251: 73-79.
46. Hellstrand, K., and S. Hermodsson. 1987. Role of serotonin in the regulation of human natural killer cell cytotoxicity. J. Immunol. 139: 869-875. (Pubitemid 17107090)
47. Oláh, T., I. Ocsovszki, Y. Mándi, R. Pusztai, M. Bakay, and E. Balint. 2005. Opposite effects of serotonin and interferon-alpha on the membrane potential and function of human natural killer cells. In Vitro Cell. Dev. Biol. Anim. 41: 165-170. (Pubitemid 41324579)
48. Mihara, T., M. Nakashima, A. Kuroiwa, Y. Akitake, K. Ono, M. Hosokawa, T. Yamada, and M. Takahashi. 2008. Natural killer cells of Parkinson's disease patients are set up for activation: a possible role for innate immunity in the pathogenesis of this disease. Parkinsonism Relat. Disord. 14: 46-51.
49. Niwa, F., N. Kuriyama, M. Nakagawa, and J. Imanishi. 2012. Effects of peripheral lymphocyte subpopulations and the clinical correlation with Parkinson's disease. Geriatr. Gerontol. Int. 12: 102-107.
50. Araga, S., H. Kagimoto, K. Funamoto, and K. Takahashi. 1991. Reduced natural killer cell activity in patients with dementia of the Alzheimer type. Acta Neurol. Scand. 84: 259-263.
51. Solerte, S. B., M. Fioravanti, A. Pascale, E. Ferrari, S. Govoni, and F. Battaini. 1998. Increased natural killer cell cytotoxicity in Alzheimer's disease may involve protein kinase C dysregulation. Neurobiol. Aging 19: 191-199.
52. Solerte, S. B., L. Cravello, E. Ferrari, and M. Fioravanti. 2000. Overproduction of IFN-γ and TNF-α from natural killer (NK) cells is associated with abnormal NK reactivity and cognitive derangement in Alzheimer's disease. Ann. N. Y. Acad. Sci. 917: 331-340.
53. Morandi, B., P. Bramanti, I. Bonaccorsi, E. Montalto, D. Oliveri, G. Pezzino, M. Navarra, and G. Ferlazzo. 2008. Role of natural killer cells in the pathogenesis and progression of multiple sclerosis. Pharmacol. Res. 57: 1-5.
54. Infante-Duarte, C., A. Weber, J. Krätzschmar, T. Prozorovski, S. Pikol, I. Hamann, J. Bellmann-Strobl, O. Aktas, J. Dörr, J. Wuerfel, et al. 2005. Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J. 19: 1902-1904. (Pubitemid 41598789)
55. bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-β. Neurol. Sci. 28: 121-126.
56. bright natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl. Acad. Sci. USA 103: 5941-5946.
57. Airas, L., M. Saraste, S. Rinta, I. Elovaara, Y. H. Huang, and H. Wiendl; Finnish Multiple Sclerosis and Pregnancy Study Group. 2008. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clin. Exp. Immunol. 151: 235-243.
58. Hamann, I., N. Unterwalder, A. E. Cardona, C. Meisel, F. Zipp, R. M. Ransohoff, and C. Infante-Duarte. 2011. Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells. Immunology 133: 62-73.
59. Lee, K., and F. Rincon. 2012. Pulmonary complications in patients with severe brain injury. Crit. Care Res. Pract. 2012: 207247.
60. Meisel, C., J. M. Schwab, K. Prass, A. Meisel, and U. Dirnagl. 2005. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 6: 775-786. (Pubitemid 41679240)
61. Quattrocchi, K. B., E. H. Frank, C. H. Miller, A. Amin, B. W. Issel, and F. C. Wagner, Jr. 1991. Impairment of helper T-cell function and lymphokine-activated killer cytotoxicity following severe head injury. J. Neurosurg. 75: 766-773.
62. Cruse, J. M., R. E. Lewis, Jr., G. R. Bishop, W. F. Kliesch, E. Gaitan, and R. Britt. 1993. Decreased immune reactivity and neuroendocrine alterations related to chronic stress in spinal cord injury and stroke patients. Pathobiology 61: 183-192. (Pubitemid 23274185)
63. Campagnolo, D. I., D. Dixon, J. Schwartz, J. A. Bartlett, and S. E. Keller. 2008. Altered innate immunity following spinal cord injury. Spinal Cord 46: 477-481. (Pubitemid 351948246)
64. Mrakovcic-Sutic, I., V. S. Tokmadzic, G. Laskarin, H. Mahmutefendic, P. Lucin, Z. Zupan, and A. Sustic. 2010. Early changes in frequency of peripheral blood lymphocyte subpopulations in severe traumatic brain-injured patients. Scand. J. Immunol. 72: 57-65.
65. Vogelgesang, A., U. Grunwald, S. Langner, R. Jack, B. M. Bröker, C. Kessler, and A. Dressel. 2008. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39: 237-241.
66. Urra, X., A. Cervera, N. Villamor, A. M. Planas, and A. Chamorro. 2009. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 158: 1174-1183.
67. Peterfalvi, A., T. Molnar, M. Banati, G. Pusch, E. Miko, L. Bogar, J. Pal, L. Szereday, and Z. Illes. 2009. Impaired function of innate T lymphocytes and NK cells in the acute phase of ischemic stroke. Cerebrovasc. Dis. 28: 490-498.
68. Prass, K., C. Meisel, C. Höflich, J. Braun, E. Halle, T. Wolf, K. Ruscher, I. V. Victorov, J. Priller, U. Dirnagl, et al. 2003. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 198: 725-736. (Pubitemid 37087772)
69. Bosch, J. A., G. G. Berntson, J. T. Cacioppo, and P. T. Marucha. 2005. Differential mobilization of functionally distinct natural killer subsets during acute psychologic stress. Psychosom. Med. 67: 366-375. (Pubitemid 40727149)
70. Segerstrom, S. C., and G. E. Miller. 2004. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 130: 601-630. (Pubitemid 38882638)
71. Benschop, R. J., M. Schedlowski, H. Wienecke, R. Jacobs, and R. E. Schmidt. 1997. Adrenergic control of natural killer cell circulation and adhesion. Brain Behav. Immun. 11: 321-332. (Pubitemid 28108141)
72. Irwin, M., U. Lacher, and C. Caldwell. 1992. Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects. Psychol. Med. 22: 1045-1050. (Pubitemid 23007015)
73. Evans, D. L., J. D. Folds, J. M. Petitto, R. N. Golden, C. A. Pedersen, M. Corrigan, J. H. Gilmore, S. G. Silva, D. Quade, and H. Ozer. 1992. Circulating natural killer cell phenotypes in men and women with major depression: relation to cytotoxic activity and severity of depression. Arch. Gen. Psychiatry 49: 388-395.
74. Frank, M. G., S. E. Hendricks, D. R. Johnson, J. L. Wieseler, and W. J. Burke. 1999. Antidepressants augment natural killer cell activity: in vivo and in vitro. Neuropsychobiology 39: 18-24. (Pubitemid 29037760)
75. Bush, K. A., K. Krukowski, J. L. Eddy, L. W. Janusek, and H. L. Mathews. 2012. Glucocorticoid receptor mediated suppression of natural killer cell activity: identification of associated deacetylase and corepressor molecules. Cell. Immunol. 275: 80-89.
76. Denys, D., S. Fluitman, A. Kavelaars, C. Heijnen, and H. Westenberg. 2004. Decreased TNF-α and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology 29: 945-952. (Pubitemid 38716121)
77. Enstrom, A. M., L. Lit, C. E. Onore, J. P. Gregg, R. L. Hansen, I. N. Pessah, I. Hertz-Picciotto, J. A. Van de Water, F. R. Sharp, and P. Ashwood. 2009. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav. Immun. 23: 124-133.
78. Popa, N., O. Cedile, X. Pollet-Villard, C. Bagnis, P. Durbec, and J. Boucraut. 2011. RAE-1 is expressed in the adult subventricular zone and controls cell proliferation of neurospheres. Glia 59: 35-44.
79. Hamann, I., J. Dörr, R. Glumm, C. Chanvillard, A. Janssen, J. M. Millward, F. Paul, R. M. Ransohoff, and C. Infante-Duarte. 2013. Characterization of natural killer cells in paired CSF and blood samples during neuroinflammation. J. Neuroimmunol. 254: 165-169
80. Fu, B., F. Wang, R. Sun, B. Ling, Z. Tian, and H. Wei. 2011. CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. Immunology 133: 350-359.
81. Krumbholz, M., D. Theil, F. Steinmeyer, S. Cepok, B. Hemmer, M. Hofbauer, C. Farina, T. Derfuss, A. Junker, T. Arzberger, et al. 2007. CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions. J. Neuroimmunol. 190: 72-79. (Pubitemid 47625610)
82. Wilbanks, G. A., and J. W. Streilein. 1992. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via a mechanism involving transforming growth factor-β. Eur. J. Immunol. 22: 1031-1036.
83. Marcoe, J. P., J. R. Lim, K. L. Schaubert, N. Fodil-Cornu, M. Matka, A. L. McCubbrey, A. R. Farr, S. M. Vidal, and Y. Laouar. 2012. TGF-β is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy. Nat. Immunol. 13: 843-850.
84. Vaquero, J., S. Coca, J. Escandón, R. Magallón, and R. Martínez. 1990. Immunohistochemical study of IOT-10 natural killer cells in brain metastases. Acta Neurochir. (Wien) 104: 17-20. (Pubitemid 20202090)
85. Stevens, A., I. Klöter, and W. Roggendorf. 1988. Inflammatory infiltrates and natural killer cell presence in human brain tumors. Cancer 61: 738-743. (Pubitemid 18037925)
86. Yang, I., S. J. Han, M. E. Sughrue, T. Tihan, and A. T. Parsa. 2011. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. J. Neurosurg. 115: 505-511.
87. Alvarez-Breckenridge, C. A., J. Yu, R. Price, J. Wojton, J. Pradarelli, H. Mao, M. Wei, Y. Wang, S. He, J. Hardcastle, et al. 2012. NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors. Nat. Med. 18: 1827-1834.
88. Holub, M., Z. Klucková, O. Beran, V. Aster, and A. Lobovská. 2002. Lymphocyte subset numbers in cerebrospinal fluid: comparison of tick-borne encephalitis and neuroborreliosis. Acta Neurol. Scand. 106: 302-308. (Pubitemid 35177999)
89. Amor, S., F. Puentes, D. Baker, and P. van der Valk. 2010. Inflammation in neurodegenerative diseases. Immunology 129: 154-169.
90. Zou, Y., T. Chen, M. Han, H. Wang, W. Yan, G. Song, Z. Wu, X. Wang, C. Zhu, X. Luo, and Q. Ning. 2010. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J. Immunol. 184: 466-475.
91. Baron, R., A. Nemirovsky, I. Harpaz, H. Cohen, T. Owens, and A. Monsonego. 2008. IFN-γ enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease. FASEB J. 22: 2843-2852.
92. Gaddi, P. J., M. J. Crane, M. Kamanaka, R. A. Flavell, G. S. Yap, and T. P. Salazar-Mather. 2012. IL-10 mediated regulation of liver inflammation during acute murine cytomegalovirus infection. PLoS ONE 7: e42850.
93. Huang, D., F. D. Shi, S. Jung, G. C. Pien, J. Wang, T. P. Salazar-Mather, T. T. He, J. T. Weaver, H. G. Ljunggren, C. A. Biron, et al. 2006. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20: 896-905. (Pubitemid 44943947)
94. Durrenberger, P. F., A. Ettorre, F. Kamel, L. V. Webb, M. Sim, R. S. Nicholas, O. Malik, R. Reynolds, R. J. Boyton, and D. M. Altmann. 2012. Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1). J. Neuroinflammation 9: 1.
95. Al Nimer, F., R. Lindblom, M. Ström, A. O. Guerreiro-Cacais, R. Parsa, S. Aeinehband, T. Mathiesen, O. Lidman, and F. Piehl. 2013. Strain influences on inflammatory pathway activation, cell infiltration and complement cascade after traumatic brain injury in the rat. Brain Behav. Immun. 27: 109-122.
96. Vaquero, J., M. Zurita, and S. Coca. 2012. Clinical behavior in metastatic brain disease is not influenced by the immunological defense mediated by CD57 NK-cells. Int. J. Surg. Oncol. 2012: 834852.